2007
DOI: 10.1016/j.vaccine.2007.07.049
|View full text |Cite
|
Sign up to set email alerts
|

Epidemiology and costs of herpes zoster: Background data to estimate the impact of vaccination

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

11
44
1

Year Published

2010
2010
2024
2024

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 46 publications
(56 citation statements)
references
References 26 publications
11
44
1
Order By: Relevance
“…The disease burden of herpes zoster in Korea was considerably higher than that reported for other countries, [26][27][28] and it has been increasing continuously during the last 5 years. The reason for this disparity is not clear, although it seems to be related to an increase in the ratio of the elderly population to the total domestic population and in the incidence and treatment of chronic diseases that weakens the immune system.…”
Section: Discussionmentioning
confidence: 60%
“…The disease burden of herpes zoster in Korea was considerably higher than that reported for other countries, [26][27][28] and it has been increasing continuously during the last 5 years. The reason for this disparity is not clear, although it seems to be related to an increase in the ratio of the elderly population to the total domestic population and in the incidence and treatment of chronic diseases that weakens the immune system.…”
Section: Discussionmentioning
confidence: 60%
“…22, 23, 30, 32, 34e36 Hospitalization rates considering only primary diagnoses of HZ are similar in our region to the average rate for Spain and slightly lower to those found in other similar regions, which ranged between 3.1 and 6.9 per 100,000 personyear. 21,22,32,34,35 This variation may reflect the differing admission criteria in the different settings, as well as …”
Section: Discussionmentioning
confidence: 99%
“…Two studies in Spain found a proportion of complicated HZ around 45%, 12,23 and in other outward studies it ranged from 33.7% to 43.5%. 22,35 This range appears to be wider when only hospitalizations with HZ as principal diagnosis are considered, reaching a 58.5%. 30,32 Complications stemming from the peripheral and central nervous systems dominated (including postherpetic neuralgia), quite similar to the findings at national and international levels.…”
Section: Complicationsmentioning
confidence: 96%
“…1 HZ significantly impacts on health, quality of life and medical costs; 1-3 the impacts increase with age. 2,[4][5][6] The primary burden of HZ is pain. 7,8 HZ pain typically occurs acutely but can persist after the rash resolves (postherpertic neuralgia [PHN]); 8% to 27% of HZ patients report pain lasting at least 3 months following rash onset.…”
Section: Introductionmentioning
confidence: 99%